Site Management/Investigator Payments Featured Articles

1. The Case For Research-Naive PIs 1/9/2026

   Carrie Lewis, executive director, clinical program optimization, at Keenova (formerly Endo) explains why research-naive PIs may improve trial quality, challenge assumptions about ROI, and help fix a shrinking investigator pipeline.

2. How Should Scientific Focus Change In 2026? Researchers Weigh In 1/8/2026

   To kick off 2026, clinical researchers share how they think research should change in the new year.

3. 2026: From Experimentation To Operational Reality In Clinical Research 1/6/2026

   Velocity Clinical Research COO Nick Spittal shares several trends he sees shaping up for 2026.

4. The Hidden Work That Keeps AMC Trials Moving 12/29/2025

   After a chance LinkedIn connection led to a conversation with Paul Antaby of MD Anderson, I got an inside look at how clinical trials really operate inside a major academic medical center. From material transfer agreements and data governance to recruitment, scale, and CRC burnout, this interview reveals the hidden work that keeps AMC trials moving — and why they operate so differently from community sites.

5. Is Your Team Burnt Out? Discover The ROI Of Healthy Employees Running Trials 12/23/2025

   Clinical trials require attention to detail, but one key variable is often overlooked: the physical, mental, and emotional wellbeing of the people behind the science and operations. How can companies make sure their workforce is ready and able to perform in high-stakes drug development?

6. 6 Pillars To Support Community Hospitals' First Steps Into Clinical Trials 12/22/2025

   Discover six pillars community hospitals can leverage to make a compelling case for clinical trials: dedicated infrastructure, community engagement, technology platforms, financial support, strategic partnerships, and physician engagement.

7. 2 Expectations & 2 Warnings For The Year Ahead 12/19/2025

   Just when I thought I was done with 2026 predictions for the clinical trial industry, three members of my editorial board emailed me some great ones, hence, part 3 of this series. What’s interesting is that two of these submissions, coincidentally, are focused on optimism for AI. In contrast, Denise Bronner’s forecast for the coming year is much more … well, dire.

8. More 2026 Clinical Predictions 12/17/2025

   Part 2 of this 2026 forecast series dives deeper into the operational friction points the clinical trials industry still hasn’t resolved. Industry leaders weigh in on sponsor–site partnerships under strain, the growing tech burden on sites, consolidation across site networks and platforms, the limits of AI hype, and why human connection may end up being the most important “innovation” of all.

9. Poland: An Underestimated Clinical Trials Powerhouse 12/15/2025

   Poland is not “one of the good options” or “an interesting emerging market," says Tomasz Szelag, head of clinical operations, Ryvu Therapeutics. Rather, it should be one of the first places sponsors look to run their clinical trials.

10. The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity 12/10/2025

    Discover how AI ambient listening has changed the way Mikel Daniels, DPM, MBA, and his team conduct clinical research at WeTreatFeet Podiatry.